Low-and middle-income countries chose not to order the vaccine from Pfizer and BioNTech. This was announced by the chief executive officer of the American company Pfizer, Albert Burla, according to Bloomberg.
In fact, high-income states have reserved most of the doses, вЂњ he said in a letter to the company's employees.
Burla noted that the authorities of middle-and low-income countries preferred to place orders from other manufacturers of coronavirus vaccines, although the drug would have been cheaper for them than for rich countries.
At the same time, Burla stressed that in 2021, Pfizer and BioNTech plan to deliver 3 billion doses of the vaccine to more than 116 countries.
Earlier it became known that American scientists are sounding the alarm вЂ” according to the results of a new study, the COVID vaccine from Pfizer and BioNTech causes long-term neurological disorders, including Alzheimer's disease and amyotrophic lateral sclerosis, known as Lou Gehrig's disease.